| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/01/2008 | CN101274962A Antibodies against human IL-12 |
| 10/01/2008 | CN101274090A Compound formulation of tablets for improving sleeping quality, tonifying qi and invigorating liver and producing process thereof |
| 10/01/2008 | CN101274087A Chinese medicine decoction for invigorating gallbladder and removing gall-stone |
| 10/01/2008 | CN101274082A Decoction for curing cold dysentery |
| 10/01/2008 | CN101274081A Paste for reinforcing spleen and promoting digestion |
| 10/01/2008 | CN101274078A Natural plant extract and preparing method and application of the same |
| 10/01/2008 | CN101274077A Medicament composition for curing children's anorexia and preparation thereof |
| 10/01/2008 | CN101274076A Kangerling granule quality control method |
| 10/01/2008 | CN101274070A Compound formulation of capsules for curing dizziness and night sweat and preparing process |
| 10/01/2008 | CN101274061A Compound formulation of capsules for nourishing yin and preparing process |
| 10/01/2008 | CN101274059A Method for preparing black plaster |
| 10/01/2008 | CN101274054A Compound formulation of mouth ulcer tablets and producing process |
| 10/01/2008 | CN101274048A Compound formulation of capsules for curing injuries from falls and preparing technique |
| 10/01/2008 | CN101274044A Medicament for preventing and treating fatty liver and method of preparing the same |
| 10/01/2008 | CN101274036A Method for testing quality criteria of conghuang preparation for tonifying kidney |
| 10/01/2008 | CN101274031A Medicament composition for curing irritable bowel syndrome |
| 10/01/2008 | CN101274030A Compound formulation of capsules for invigorating yang and preparing technique |
| 10/01/2008 | CN101274028A Liver health care composition and preparation thereof |
| 10/01/2008 | CN101274025A Chinese medicinal composition with functions of reducing fever, purging the intense heat and detoxicating and preparation method thereof and quality control method |
| 10/01/2008 | CN101274024A Pharmaceutical compositions for curing toothache |
| 10/01/2008 | CN101274014A Medicine for curing chronic hepatitis B and posthepatitic cirrhosis |
| 10/01/2008 | CN101273973A Pharmaceutical combination containing Mosapride citrate and method of preparing the same |
| 10/01/2008 | CN101273789A Summer-heat clearing beverage and its preparing method |
| 10/01/2008 | CN101273787A Pure Chinese medicinal health care black-bone chicken |
| 10/01/2008 | CN101273773A Health-care Chinese herbal medicine seasoning sauces |
| 10/01/2008 | CN101273745A Health care tea for moistening intestines |
| 10/01/2008 | CN101273744A Method for processing Seabuckthorn tea drinks and seabuckthorn tea drinks using this method |
| 10/01/2008 | CN100422316C Neutralizing human anti-IGFR antibody |
| 10/01/2008 | CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 10/01/2008 | CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/01/2008 | CN100422186C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100421725C Chinese medicine composition for treating gastritis and preparing method thereof |
| 10/01/2008 | CN100421724C Traditional medicine composition for treating chronic colitis and its preparing process |
| 10/01/2008 | CN100421709C Medicine for treating cirrhosis ascites |
| 10/01/2008 | CN100421705C Method of extracting compound male moth hidney fortifying raw material possesing improving sexual living quality from pure Chinese medicinal preparation |
| 10/01/2008 | CN100421698C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421697C Synergistic medicinal composition containing diammonium glycyrrhizinate and Chinese medicine |
| 10/01/2008 | CN100421694C Method of extracting gastroenteric power enbancing medicament from natural plant Chinese medicine effective component |
| 10/01/2008 | CN100421693C Chinese patent medicine for treating anal fissure |
| 10/01/2008 | CN100421692C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| 10/01/2008 | CN100421691C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421688C Synergistic medicinal composition containing thiopronin and Chinese medicine extract |
| 10/01/2008 | CN100421687C Chinese medicine for treating kidney insufficiency |
| 10/01/2008 | CN100421686C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421677C Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn. |
| 10/01/2008 | CN100421651C Schisantherin A dispersible tablet and preparation process thereof |
| 10/01/2008 | CN100421648C Hydrocortisone clyster agent and method for preparing the same |
| 09/30/2008 | USRE40525 Hepatitis C inhibitor tri-peptides |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429607 5-HT2B receptor antagonists |
| 09/30/2008 | US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 09/30/2008 | US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | CA2371031C Compositions for treatment of disorders of the oesophagus |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/30/2008 | CA2274076C Crystalline form of s-omeprazole |
| 09/30/2008 | CA2183050C Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 09/25/2008 | WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 09/25/2008 | WO2008115140A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 09/25/2008 | WO2008114971A1 Novel benzamide derivatives and process for the preparation thereof |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114787A1 Antiviral agent |
| 09/25/2008 | WO2008114503A1 Composition for improving intestinal microflora |
| 09/25/2008 | WO2008114123A1 Spiro benzimidazole derivatives as acid pump inhibitors |
| 09/25/2008 | WO2008113929A1 Pharmaceutical composition containing phloroglucinol and paracetamol |
| 09/25/2008 | WO2008113905A1 Use of clay for treating coeliac disease |
| 09/25/2008 | WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 09/25/2008 | WO2008091540A3 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 09/25/2008 | US20080234376 Prostaglandin E1, a phospholipid with a high purity and a non-proton-providing surfactant; hypertension, thrombosis, asthma, gastric and intestinal ulcers |
| 09/25/2008 | US20080234370 Calcilytic Compounds |
| 09/25/2008 | US20080234368 Therapeutic compositions and methods of use |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234345 Method for reducing or alleviating inflammation in the digestive tract |
| 09/25/2008 | US20080234326 Calcium (S)-bis{[5-(difluoromethoxy)]-2-[(3,4-dimethoxy-2-pyridinyl)methyl-sulphinyl]-1H-benzimidazolide}; gastrointestinal disorder |
| 09/25/2008 | US20080234325 Novel Methods Using Pyridine Derivatives |
| 09/25/2008 | US20080234316 Quinuclidine Amide Derivatives |
| 09/25/2008 | US20080234312 Feed or Feed Additive Containing an Alkaloid |
| 09/25/2008 | US20080234307 Novel 6-Amino-Morphinan Derivatives, Method of Manufacturing Them and Their Application as Analgesics |
| 09/25/2008 | US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases |
| 09/25/2008 | US20080234282 Especially 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives: 4-{[2-(3,chloro-4-fluorophenyl)-2-piperazin-1-ylethoxy]methyl}-3-methoxy-2-naphthonitrile; neurokinin 1 antagonists; antidepressants |
| 09/25/2008 | US20080234258 Dihydroxyanthraquinones and Their Use |
| 09/25/2008 | US20080234230 Pharmaceutical Composition for Regulation of Pancreatic Juice Secretion Comprising a LPA Receptor Modulator |
| 09/25/2008 | US20080234226 Use Of Iron(III) Complex Compounds For The Preparation Of A Medicament For Oral Treatment Of Iron Deficiency States In Patients With Chronic Inflammatory Bowel Disease |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234199 Chemical Compounds |
| 09/25/2008 | US20080233649 Progenitor cells; serum-free; differentiation; cloning |
| 09/25/2008 | US20080233642 Mammalian immortalized liver cell |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233220 Use of botanical ingredients from a species of each of the genera Silybum, Astragalus or Hedysarum, Salvia, and Schisandra for treatment of liver inflammation associated with hepatitis B virus, alcohol abuse, metabolic disorders associated with the liver, or chemotherapy side effects |
| 09/25/2008 | US20080233193 Oral antimicrobial pharmaceutical compositions |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
| 09/25/2008 | US20080233127 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | US20080233113 Cardiovascular conditions, ischemia-reperfusion injury, atherosclerosis, inflammatory gastrointestinal disorder, pulmonary condition, musculoskeletal conditions, renal conditions, skin conditions, organ or tissue transplants, nervous system disorders |
| 09/25/2008 | US20080233104 Probiotic, lactic acid-producing bacteria and uses thereof |
| 09/25/2008 | US20080233078 Therapeutic polyesters and polyamides |
| 09/25/2008 | CA2681466A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |